SOL 创新高,「Meme 链之王」能成为第三只现货 ETF?

Allcyte

company

About

Allcyte is a biotech start-up focused on precision medicine and drug development in a patient-centric way using high-content imaging and AI

  • 11 - 50

Details

Last Funding Type
Seed
Last Funding Money Raised
$6M
Industries
Biotechnology,Health Diagnostics,Machine Learning,Pharmaceutical
Founded date
Jan 1, 2017
Number Of Employee
11 - 50
Operating Status
Active

Allcyte is a biotech start-up company focused on functional drug testing in primary human material. With our Pharmacoscopy high-content imaging platform and AI-supported image analysis pipelines, our mission is to bring the next generation of personalized medicine to cancer patients and treating physicians, and support pharmaceutical companies to focus their drug development efforts on the right molecules in the right indications.

We enable research through the image-based quantification of single-cell phenotypes - all performed directly in primary patient material with minimal amounts of manipulation and requiring minimal amounts of sample. We integrate these data using cutting edge methods of statistics and machine learning to generate actionable insights for our customers. Our mission is to help you make the best possible biomedical decisions.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
1
$6M
Allcyte has raised a total of $6M in funding over 2 rounds. Their latest funding was raised on Jul 1, 2020 from a Seed round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Jul 1, 2020 Seed $6M 1 Detail

Investors

Number of Lead Investors
Number of Investors
1
Allcyte is funded by 1 investors. Venture Partners AG are the most recent investors.
Investor Name Lead Investor Funding Round
Venture Partners AG Seed